Get the Stockscreener App
0.9238
1.13%
-0.0106
After Hours:
.92
-0.0038
-0.41%
Canopy Growth Corporation stock is traded at $0.9238, with a volume of 2.09M.
It is down -1.13% in the last 24 hours and down -12.02% over the past month.
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
See More
Previous Close:
$0.9344
Open:
$0.9239
24h Volume:
2.09M
Relative Volume:
0.55
Market Cap:
$390.80M
Revenue:
$199.30M
Net Income/Loss:
$-230.47M
P/E Ratio:
-0.7166
EPS:
-1.2891
Net Cash Flow:
$-58.89M
1W Performance:
-1.56%
1M Performance:
-12.02%
6M Performance:
-2.22%
1Y Performance:
-32.57%
1-Day Range:
$0.9155
$0.94
1-Week Range:
$0.9146
$0.95
52-Week Range:
$0.8435
$2.38
Canopy Growth Corporation Stock (CGC) Company Profile
Name
Canopy Growth Corporation
Sector
Phone
855-558-9333
Address
1 Hershey Drive, Smiths Falls, ON
Compare CGC vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGC
Canopy Growth Corporation
|
0.9238 | 392.45M | 199.30M | -230.47M | -58.89M | -1.2891 |
TAK
Takeda Pharmaceutical Co Adr
|
18.89 | 58.31B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
40.06 | 43.22B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.36 | 40.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
71.33 | 30.15B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
493.10 | 21.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Initiated | Canaccord Genuity | Buy |
| Nov-10-25 | Upgrade | The Benchmark Company | Sell → Hold |
| Apr-04-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Nov-02-22 | Initiated | Bernstein | Underperform |
| Oct-26-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-08-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Mar-22-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-22-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-20-21 | Downgrade | Piper Sandler | Neutral → Underweight |
| Dec-07-21 | Initiated | Wells Fargo | Underweight |
| Nov-18-21 | Initiated | Barclays | Equal Weight |
| Nov-08-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Nov-08-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Nov-08-21 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-01-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-21 | Upgrade | Jefferies | Underperform → Hold |
| Jun-02-21 | Upgrade | Canaccord Genuity | Sell → Hold |
| May-25-21 | Upgrade | MKM Partners | Neutral → Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-24-21 | Downgrade | Jefferies | Hold → Underperform |
| Feb-10-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-10-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-05-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-04-20 | Upgrade | CFRA | Buy → Strong Buy |
| Jun-01-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jun-01-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Jun-01-20 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-01-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-01-20 | Downgrade | Stifel | Buy → Sell |
| May-22-20 | Resumed | BofA/Merrill | Buy |
| Apr-16-20 | Upgrade | Jefferies | Underperform → Hold |
| Jan-28-20 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-19 | Reiterated | Cantor Fitzgerald | Neutral |
| Nov-20-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-15-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-14-19 | Downgrade | Seaport Global Securities | Buy → Neutral |
| Oct-11-19 | Downgrade | Jefferies | Hold → Underperform |
| Sep-27-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-18-19 | Initiated | Oppenheimer | Perform |
| Aug-26-19 | Upgrade | Seaport Global Securities | Neutral → Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Buy |
View All
Canopy Growth Corporation Stock (CGC) Latest News
Canopy Growth: Business Profile and TSX Market Context - Kalkine Media
Canopy Growth Corporation Share PriceWEED, RNS News, Articles, Quotes, & Charts (TSE:WEED: ) - Proactive financial news
Week in Weed – September 12, 2026 - StratCann
Cannabis - Proactive financial news
What is moving Canopy Growth (NASDAQ:CGC) shares in today's market? - Kalkine Media
Canopy Growth (TSX:WEED) Fuels New Interest Across Cannabis Markets Midcap Stocks - Kalkine Media
Canopy Growth (NASDAQ:CGC): What's Driving Amid A Cautious Session? - Kalkine Media
What Is Driving Interest in Canopy Growth (NASDAQ:CGC)? - Kalkine Media
Canopy Growth broadens Australian medical cannabis portfolio with new formats and formulations - MMJDaily
Why Is the Market Watching Canopy Growth? (NASDAQ:CGC) - Kalkine Media
What's Driving Canopy Growth Corporation (TSX:WEED) Right Now? - Kalkine Media
Can Canopy Growth (NASDAQ:CGC) Turn Revenue Growth Into a Real Turnaround? - Kalkine Media
Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats, Formulations - cannabisbusinesstimes.com
CGC Looks 39.2% Overvalued on GF Value™ - GuruFocus
Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations - Yahoo Finance
Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. Here's Why. - Yahoo Finance
Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. Here's Why. - The Motley Fool
Should You Buy Canopy Growth Stock on the Rebound? - The Motley Fool
Canopy Growth (NASDAQ:CGC): Is Cannabis Sentiment Turning Again? - Kalkine Media
Why Is Canopy Growth (NASDAQ:CGC) Narrowing Annual Losses as Stockholders Prepare to Vote on Share Consolidation? - Kalkine Media
Why Cannabis Stocks Like Canopy Growth (TSX:WEED) Matter Now - kalkinemedia.com
Canopy Growth (NASDAQ:CGC) Builds A New Case for Cannabis Growth - Kalkine Media
Canopy Growth Company Profile & Introduction - Moomoo
Canopy Growth (NASDAQ:CGC) Narrows Loss As Europe Drives Growth - Kalkine Media
Promising Cannabis Stocks To Watch NowSeptember 2nd - MarketBeat
Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands? - Yahoo Finance
Is Canopy Growth (NASDAQ:CGC) Turning the Corner on Margins? - Kalkine Media
Canopy Growth (NASDAQ:CGC) Revenue Turns Higher After Fiscal Reset - Kalkine Media
Top Cannabis Stocks Worth WatchingSeptember 1st - MarketBeat
What Is Driving Canopy Growth Stock? (NASDAQ:CGC) - Kalkine Media
Is Canopy Growth (NASDAQ:CGC) Turning a Corner as Vaporizer Sales and European Shipments Climb? - Kalkine Media
Can Canopy Growth (TSX:WEED) Regain Canada Market Attention? - Kalkine Media
Canopy Growth (NASDAQ:CGC) Could Benefit From A Cannabis Policy Shift - Kalkine Media
Canopy Growth (TSX:WEED) Faces Changing Cannabis Market Dynamics - Kalkine Media
How Is a Streamlined Strategy Reshaping the Story Around Canopy Growth (NASDAQ:CGC)? - Kalkine Media
Can Canopy Growth (TSX:WEED) Navigate Canada’s Cannabis Reset? - Kalkine Media
Canopy Growth Stock Falls 2.80%: Is TSX:WEED Facing Renewed Pressure as Cannabis Recovery Remains Uncertain? - kalkine.ca
Is Canopy Growth (NASDAQ:CGC) turning a corner as cannabis reform talk revives? - kalkinemedia.com
Canopy Growth Corporation Revenue Breakdown – TSX:WEED - TradingView
Canopy Growth (NASDAQ:CGC): Can Margin Gains Fuel Momentum? - kalkinemedia.com
Canopy Focuses On Fundamentals Ditching ‘Financial Instrument’ Era - Business of Cannabis
Why Canopy Growth (NASDAQ:CGC) Faces New Industry Challenges? - Kalkine Media
Canopy Growth publishes FY2026 annual report - Bitget
Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell? - The Globe and Mail
Why Is Canopy Growth (NASDAQ:CGC) Facing a Regulatory Test? - Kalkine Media
Canopy Growth (NASDAQ:CGC): Cannabis Industry Shifts in Focus - Kalkine Media
Why Is Canopy Growth (NASDAQ:CGC) in Focus Today? - Kalkine Media
What Does Today’s Federal Cannabis Update Mean for Canopy Growth (NASDAQ:CGC)? - Kalkine Media
How Is Canopy Growth (NASDAQ:CGC) Shaping Its Market Narrative? - Kalkine Media
Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here’s Why TLRY Is Still Down 47% YTD - Yahoo Finance
Canopy (CGC) Quarterly Results: The Available Earnings Metric Delivers a Beat in the Latest Reading; Trading Move: The Stock Records a 1.00% Decrease for the Current SessionGuidance Update - Vinanet
Canopy Growth Corporation Stock (CGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Canopy Growth Corporation Stock (CGC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Gedeon Christelle | See Remarks |
Aug 24 '26 |
Sale |
1.47 |
13,344 |
19,616 |
692,162 |
| Stewart Thomas Carlton | See Remarks |
Aug 24 '26 |
Sale |
1.47 |
2,231 |
3,280 |
614,167 |
| BAYERN JOSEPH | Director |
Jun 26 '26 |
Sale |
0.92 |
3,197 |
2,953 |
145,127 |
| Yanofsky Theresa | Director |
Jun 26 '26 |
Sale |
0.92 |
15,054 |
13,905 |
146,415 |
| ATKINS M SHAN | Director |
Jun 26 '26 |
Sale |
0.92 |
3,197 |
2,953 |
146,517 |
| Lazzarato David Angelo | Director |
Jun 26 '26 |
Sale |
0.92 |
22,674 |
20,944 |
211,859 |
| Stewart Thomas Carlton | See Remarks |
Jun 17 '26 |
Sale |
0.97 |
9,285 |
9,045 |
616,398 |
| Gedeon Christelle | See Remarks |
Jun 17 '26 |
Sale |
0.97 |
58,994 |
57,466 |
705,506 |
| Mongeau Luc | Chief Executive Officer |
Jun 17 '26 |
Sale |
0.97 |
135,231 |
131,729 |
1,723,913 |
| Yanofsky Theresa | Director |
Mar 31 '26 |
Sale |
0.93 |
10,373 |
9,647 |
53,145 |
1.82%
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):